CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites

W R Weiss, M Sedegah, R L Beaudoin, L H Miller, M F Good, W R Weiss, M Sedegah, R L Beaudoin, L H Miller, M F Good

Abstract

In recent malaria sporozoite vaccine trials in humans and mice, antibodies to the sporozoite coat protein have given only modest protection against sporozoite challenge. In contrast, irradiated sporozoites can protect mice against massive sporozoite infections. Evidence suggests that immunity in these mice is mediated by T cells. To identify the mechanism of immunity, we used monoclonal antibodies specific for either the CD4 or CD8 molecule to selectively deplete sporozoite-immunized mice of T-cell subsets. Though in vivo depletion of CD4+ T cells did not reduce immunity, depletion of CD8+ T cells abolished protection. Monoclonal antibody treatment did not affect anti-sporozoite antibody levels. Our data indicate that cytotoxic T cells are critical for immunity to large numbers of sporozoites and suggest that vaccine development should be reoriented toward stimulating cellular as well as humoral immunity.

References

    1. J Exp Med. 1967 Sep 1;126(3):423-42
    1. Nature. 1987 Jul 16-22;328(6127):257-9
    1. J Parasitol. 1968 Dec;54(6):1175-80
    1. Am J Med Sci. 1973 Sep;266(3):169-77
    1. Trans R Soc Trop Med Hyg. 1974;68(3):258-9
    1. J Immunol. 1977 Apr;118(4):1322-7
    1. Exp Parasitol. 1977 Jun;42(1):73-81
    1. J Immunol. 1978 Sep;121(3):1031-3
    1. J Exp Med. 1979 Jul 1;150(1):108-16
    1. Immunol Rev. 1979;47:63-90
    1. J Immunol. 1981 Jun;126(6):2494-5
    1. Proc Natl Acad Sci U S A. 1981 Nov;78(11):7101-5
    1. J Immunol. 1983 Apr;130(4):1545-51
    1. J Exp Med. 1983 Oct 1;158(4):1077-91
    1. J Immunol. 1983 Nov;131(5):2445-51
    1. J Immunol. 1984 Jun;132(6):2775-82
    1. J Immunol. 1984 Aug;133(2):1005-9
    1. Nature. 1984 Dec 6-12;312(5994):548-51
    1. J Parasitol. 1984 Oct;70(5):831-3
    1. J Exp Med. 1985 Feb 1;161(2):345-55
    1. Cell Immunol. 1985 May;92(2):414-26
    1. Science. 1985 May 24;228(4702):958-62
    1. Science. 1985 May 24;228(4702):996-9
    1. Eur J Immunol. 1985 Jun;15(6):638-40
    1. J Immunol. 1985 Aug;135(2):1001-3
    1. Science. 1985 Jun 21;228(4706):1436-40
    1. J Exp Med. 1985 Aug 1;162(2):663-74
    1. J Exp Med. 1985 Dec 1;162(6):2068-88
    1. J Exp Med. 1986 Apr 1;163(4):903-21
    1. Science. 1986 May 16;232(4752):881-4
    1. Immunol Rev. 1986 Jun;91:195-218
    1. Infect Immun. 1986 Sep;53(3):628-30
    1. Nature. 1986 Aug 21-27;322(6081):687-9
    1. Infect Immun. 1987 Mar;55(3):604-8
    1. J Biol Chem. 1987 Sep 5;262(25):11935-9
    1. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8647-51
    1. J Exp Med. 1987 Feb 1;165(2):459-70
    1. Science. 1987 Apr 24;236(4800):453-6
    1. J Virol. 1987 Jun;61(6):1867-74
    1. J Immunol. 1987 Jun 15;138(12):4447-9
    1. Lancet. 1987 Jun 6;1(8545):1277-81
    1. Nature. 1967 Oct 14;216(5111):160-2

Source: PubMed

3
Subscribe